Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

about

Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.

P2860

Q40672604-B87832CC-B32F-409C-8AE6-4AA9A3FDAE68 Q47745002-D2035A05-7355-4995-BB59-772654A6CAA1

P2860

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

Item

http://www.wikidata.org/entity/Q36806891

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@ast

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@en

type

Item

label

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@ast

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@en

prefLabel

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@ast

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@en

P1476

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

@en

P2093

Aline Teotonio Rodrigues

http://www.w3.org/2001/XMLSchema#string

Rebeca Stahlschmidt

http://www.w3.org/2001/XMLSchema#string

Silvia Granja

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.

Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.

US pharmacists' effect as team members on patient care: systematic review and meta-analyses.

A critical evaluation of clinical decision support for the detection of drug-drug interactions.

Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.

Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.

Tiering drug-drug interaction alerts by severity increases compliance rates.

[Drug interactions and adverse events induced by drugs used in an intensive care unit].

Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools.

P304

366-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSPS.2014.11.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patricia Moriel

Priscila Gava Mazzola

Antonio L E Falcão

P577

2014-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273178837

http://www.w3.org/2001/XMLSchema#string

P698

27134536

http://www.w3.org/2001/XMLSchema#string

P932

4834694

http://www.w3.org/2001/XMLSchema#string

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

about

P2860

P2860

Clinical relevancy and risks of potential drug-drug interactions in intensive therapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932